trending Market Intelligence /marketintelligence/en/news-insights/trending/rsecywFa66A65XCR59BLsA2 content esgSubNav
In This List

Cimarron closes majority recapitalization of Infusion Management

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Podcast

Street Talk Episode 87

Blog

A New Dawn for European Bank M&A Top 5 Trends

Blog

Insight Weekly: US banks' loan growth; record share buybacks; utility M&A outlook


Cimarron closes majority recapitalization of Infusion Management

Salt Lake City-based private equity firm Cimarron Healthcare Capital LP, which focuses on lower-middle-market healthcare investments, acquired Thousand Oaks, Calif.-based Infusion Management.

Financial terms of the majority recapitalization and growth equity capital raise were not made public.

The acquired company is the exclusive management services organization affiliated with Infusion for Health, which provides infusion therapy treatment for Greater Los Angeles area patients with multiple sclerosis, rheumatoid arthritis, and other autoimmune and immunodeficiency disorders.

Concurrently with the deal closing, Michael Tahery was named medical director of Infusion for Health.